Addex director reprices 1.37M shares, 273K options
Addex director Raymond George Hill reported administrative option and share repricing entries, lowering exercise prices to $0.032 per share without changing other terms.
Rhea-AI Filing Summary
Addex Therapeutics Ltd. (ADXN) reported that director Raymond George Hill had paired administrative transactions on September 2, 2026 to reflect repricing of previously granted equity awards. A total of 1,365,532 shares of common stock and options over 273,107 shares were recorded as dispositions to the issuer and simultaneous grants at a reduced exercise price of $0.032 per share, while all other terms of the plans and options remained unchanged. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
Hill Raymond George
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Stock-option (Right to Buy) F3, F2 | 273,107 | $0.00 | $0.00 |
| Grant/Award | Stock-option (Right to Buy) F3, F2 | 273,107 | $0.00 | $0.00 |
| Disposition | Common Stock F1 | 1,365,532 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 1,365,532 | $0.00 | $0.00 |
Holdings After Transaction:
Stock-option (Right to Buy) — 273,107 contracts (Direct);
Common Stock — 1,365,532 shares (Direct)
Footnotes (3)
- F1. Represents 1,365,532 shares of common Stock listed on SIX Swiss Exchange acquired following the exercise of options. Of these shares, 797,563 were acquired on October 26, 2022 under the deferred strike price payment plan with an initial strike price of $0.16 per share and 567,969 were acquired on November 27, 2023 with an initial strike price of $0.053 per share. On September 2, 2026, following the implementation of the Remuneration Committee's decision, the Strike price of all units was reduced to $0.032. All the other terms of the deferred strike price payment plan remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the exchange act as applicable. The strike prices indicated in this section reflect the conversion from CHF to USD at an exchange rate of $1.2296 per CHF 1.00 as of September 2, 2026.
- F2. On September 2, 2026, following the implementation of the Remuneration Committee's decision, the exercise price of the options were repriced to $0.032. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the exchange act as applicable.
- F3. The exercise price is reported in U.S. dollars and reflects the conversion from CHF to USD at an exchange rate of $1.2296 per CHF 1.00 as of September 2, 2026.
Key Figures
Common shares affected: 1,365,532 shares
Options affected: 273,107 shares
New exercise price: $0.032 per share
+3 more
6 metrics
Common shares affected
1,365,532 shares
Shares of common stock subject to paired disposition and grant entries on September 2, 2026
Options affected
273,107 shares
Options over common stock subject to repricing entries on September 2, 2026
New exercise price
$0.032 per share
Exercise price of affected options and deferred strike units after Remuneration Committee decision
Initial strike price tranche 1
$0.16 per share
Strike price for 797,563 shares acquired on October 26, 2022 before repricing
Initial strike price tranche 2
$0.053 per share
Strike price for 567,969 shares acquired on November 27, 2023 before repricing
Currency conversion rate
$1.2296 per CHF 1.00
Rate used to convert exercise prices from Swiss francs to U.S. dollars as of September 2, 2026
Key Terms
deferred strike price payment plan, Remuneration Committee, Rule 16b-6(d), Rule 16b-3, +1 more
5 terms
deferred strike price payment plan financial
"acquired on October 26, 2022 under the deferred strike price payment plan with an initial"
Remuneration Committee financial
"On September 2, 2026, following the implementation of the Remuneration Committee's decision, the"
A remuneration committee is a group of independent board members who design, approve and oversee pay packages for a company’s executives and directors. Think of them as the household budget planners for top management: they decide salaries, bonuses and stock awards so pay rewards performance and limits excessive risk. For investors, their role matters because compensation policies affect management incentives, business strategy and the long‑term value shareholders receive.
Rule 16b-6(d) regulatory
"Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the exchange act as"
Rule 16b-3 regulatory
"Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the exchange act as"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
exchange act regulatory
"pursuant to Rule 16b-6(d) and Rule 16b-3 of the exchange act as applicable."
A federal law that sets rules for trading securities on public exchanges, requiring companies and market participants to register, disclose regular financial information, and follow standards that promote honest, orderly markets. For investors, it matters because it creates transparency and legal protections—like stopping insider trading and ensuring timely company disclosures—so you can evaluate risks and rely on consistent rules much as players rely on a referee to keep a game fair.
FAQ
What insider transactions did ADXN director Raymond George Hill report on September 2, 2026?
Raymond George Hill reported paired dispositions and grants involving 1,365,532 common shares and options over 273,107 shares, reflecting a repricing of existing awards to a new exercise price of $0.032 per share while leaving other terms unchanged.
What exercise price change was disclosed for ADXN equity awards on September 2, 2026?
The company disclosed that the exercise or strike price of the relevant options and deferred strike units was reduced to $0.032 per share on September 2, 2026, following a decision by the Remuneration Committee, with all other terms of the awards remaining the same.
Were Raymond George Hill’s ADXN transactions made under a Rule 10b5-1 trading plan?
No. The Form 4 indicates that the Rule 10b5-1 checkbox was not marked and the footnotes describe the transactions as repricing actions exempt under specific Exchange Act rules, rather than trades under a Rule 10b5-1 plan.
How were currency conversions handled in the ADXN option repricing for Raymond George Hill?
The filing explains that exercise prices are reported in U.S. dollars and that they reflect conversion from Swiss francs at an exchange rate of $1.2296 per CHF 1.00 as of September 2, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
